IN Senate Committee Votes to Restrict Medical Abortion Pill
Yesterday, the Indiana Senate health committee voted 5 to 4 to further restrict women's access to RU-486, or the abortion pill. If the bill passes, doctors would be required to conduct an in-person examination of a woman before prescribing the abortion pill, as well as give her written information of the risks of an abortion and perform a follow-up ultrasound two weeks later. Doctors who fail to comply could face misdemeanor charges.
The bill also requires that doctors follow FDA guidelines recommending that doctors prescribe a 600 milligram dose of the drug, even though studies have found 200 milligrams of the drug to be adequate. Dr. John Stutsman, medical director of Planned Parenthood of Indiana and a professor at Indiana University, indicated that the higher dosage would increase the possibility of side effects for the woman.
The Associated Press reports that mifepristone is currently used in about 15 percent of abortions in the United States. Marketed as Mifeprex in the United States, the drug provides women with more privacy than a surgical procedure does because women are able to take the pill home. Mifepristone has also increased the accessibility of abortion. Among Planned Parenthood's 322 clinics nationwide that provide abortion, almost half administer mifepristone, but do not offer surgery.
Media Resources: National Partnership for Women and Families 1/26/12; Associated Press 1/25/12; Feminist Daily Newswire 9/27/10
12/1/2015 Candlelight Vigil Calls for an End to Anti-Abortion Terrorism - Last night, dozens of activists gathered outside the Supreme Court for a candlelight vigil calling for an end to anti-abortion terrorism.
The vigil, hosted by Reproaction, included representatives from NARAL Pro-Choice America, Planned Parenthood, the Feminist Majority Foundation, GetEQUAL, the National Council of Jewish Women, and others.
Representatives Jan Schakowsky (IL) and Mike Quigley (IL) joined the crowd and spoke of the need for abortion access and an end to the dangerous anti-choice rhetoric. . . .